Skip to content

Study of Venusia® Max Cream as Moisturizer in Psoriasis

Real world, Non-interventional, Observational Study of Venusia® Max Cream as Moisturizer in Psoriasis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2017/03/008023
Enrollment
400
Registered
2017-03-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Psoriasis

Interventions

None listed

Sponsors

Dr Reddys Laboratories Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with psoriasis who have been prescribed Venusia® Max cream 2. Patients of both sexes, aged 18 years to 75 years who provide informed consent for data collection

Exclusion criteria

Exclusion criteria: 1. Those with known hypersensitivity to any ingredient of Venusia® Max cream

Design outcomes

Primary

MeasureTime frame
� Effectiveness of Venusia® Max cream in improving Quality of Life, as recorded using Dermatology Life Quality Index (DLQI) Questionnaire, at 4 weeks compared to baselineTimepoint: Baseline and 4 weeks

Secondary

MeasureTime frame
� Effectiveness of Venusia® Max cream in improvement of severity of dryness, as recorded using the Dry skin/ichthyosis Area and Severity Index (DASI) score, at 4 weeks compared to baselineTimepoint: Baseline and 4 weeks

Countries

India

Contacts

Public ContactDr Srinivas Chintakayala

Dr. Reddy;s Laboratories Ltd

srinivaschintakayala@drreddys.com04049048654

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 2, 2026